Unitree's RMB 60.99B IPO Rewrites the Valuation Rules for China's Humanoid Robot Race
China's embodied intelligence sector finally has a public price tag: Unitree Robotics priced its Science and Technology Innovation Board IPO at RMB 150.80 per share on August 6, implying a total market capitalization of RMB 60.99 billion (US$8.47 billion) — a figure that exceeded the market's pre-deal consensus of RMB 42 billion by nearly 45% and arrived at a post-issuance price-to-earnings multiple of 219.23x.
The deal's significance extends well beyond a single company's debut. Until this listing, valuations for embodied AI startups existed exclusively in the opaque corridors of China's primary market, where round-to-round markups were driven by narrative momentum rather than audited financials. Unitree's listing transfers that pricing function to institutional investors operating in full public view — a structural shift that will force every competitor still seeking capital to justify its story with hard numbers.
Market reception validated the aggression: the final offer price of RMB 150.80 per share fell just below the "four-figure floor" ceiling of RMB 152.15, the regulatory benchmark derived from the median and weighted-average bids of qualified investors including public mutual funds, social security funds, and qualified foreign institutional investors (QFIIs). Lead underwriter CITIC Securities cited this as confirmation that pricing was market-determined rather than administratively capped.
DeepSeek and Tencent Anchor a Strategic Allotment That Signals Ecosystem Convergence
The nine-member strategic allotment roster reads as a who's-who of China's AI and technology establishment. Deepseek, the large language model developer that rattled global AI markets earlier in 2026, secured an allocation alongside Tencent's investment vehicle Shanghai Qishan Investment. The Beijing Robot Industry Development Investment Fund holds a 3.83% pre-IPO stake.
The Unitree-DeepSeek pairing carries specific commercial weight. The two companies have formalized a mutual-preference arrangement: DeepSeek receives priority access to Unitree's high-performance general-purpose robots under equivalent conditions, while Unitree gains preferential access to DeepSeek's large model services. The structure represents one of the first publicly disclosed "foundation model plus hardware" commercial agreements in China's embodied intelligence sector — and suggests that the next competitive frontier is not locomotion or dexterity, but AI-native decision-making.
Tencent's position deepens an existing commitment. The company's wholly owned subsidiary Tencent already held a 0.5986% direct pre-IPO stake; the new strategic allotment through Qishan Investment carries a lock-up extending to the later of 36 months from Tencent's initial share acquisition or 12 months from listing — an unusually long horizon that signals conviction rather than opportunistic participation.
Financials Expose a Widening Gap Between Unitree and Its Closest Peers
The prospectus data that underpins the IPO pricing makes the competitive landscape stark. Unitree's revenue grew from RMB 159 million (US$22.1 million) in 2023 to RMB 1.699 billion (US$235.9 million) in 2025, a three-year compound annual growth rate of 226.78%. Net profit attributable to the parent, adjusted for non-recurring items, swung from a loss of RMB 18.02 million in 2023 to a profit of RMB 591 million (US$82.1 million) in 2025 — a 7.5-fold increase in a single year after crossing breakeven in 2024. Unitree shipped 5,511 humanoid robots in 2025, capturing a 32.4% global market share, while cumulative sales of its quadruped robots exceeded 33,000 units.
The contrast with the sector's other public benchmark is unambiguous. UBTECH Robotics, listed in Hong Kong and widely cited as the "first humanoid robot stock" on that exchange, reported 2025 revenue of approximately RMB 2 billion — modestly above Unitree — but posted a net loss of RMB 790 million, bringing its cumulative four-year loss to more than RMB 4.2 billion. DEEP Robotics, a fellow Hangzhou-based company currently queued for its own STAR Market IPO, recorded 2025 revenue of RMB 337 million and adjusted net profit of RMB 15.12 million — roughly one-eleventh of Unitree's scale, with profitability that is present but not yet meaningful.
This three-data-point matrix — revenue scale, profitability trajectory, and market share — now functions as a public coordinate system against which every private-market valuation claim in the sector will be tested. Arguments about superior technology moats or broader addressable markets, which circulated freely in a data-vacuum, will face direct scrutiny once investors can benchmark them against Unitree's audited results.
RMB 2.022B R&D Commitment Shifts the Competition Toward AI Brains
Unitree's prospectus discloses plans to deploy RMB 2.022 billion (US$280.8 million) — a substantial portion of the RMB 5.917 billion (US$821.8 million) in net proceeds — into embodied large model research and development. The allocation signals that the company views its current hardware advantage as a platform to be defended by software, not a moat in itself.
More than 70% of Unitree's current revenue derives from B2B customers in research and education. Consumer-grade applications and large-scale industrial deployment remain nascent. As a listed company, Unitree will face quarterly scrutiny on repeat-order rates in real operational environments and on whether AI model investment translates into recurring software revenue — pressure that will propagate across the entire sector.
The broader production context reinforces the timing urgency. Global humanoid robot output reached an estimated 15,000 to 20,000 units in 2025. Industry consensus designates 2026 as the first genuine mass-production year. ROBOTERA commenced thousand-unit batch deliveries in Q2 2026; Galbot is advancing deployments in industrial manufacturing and instant-retail logistics; AI² Robotics has outlined plans to install 1,000 "Zhi Magic Cube" terminal scenarios nationwide over three years. Yet sector participants interviewed by Titanium Media note that technological convergence remains incomplete, and that true large-scale deployment will require additional time. The consensus view is that once any single company demonstrably closes the commercial loop, an industry shakeout begins.
State Capital Floods the Sector, Replicating the EV Playbook
Government-linked capital is not merely a passive observer. Among the 19 newly minted robot unicorns tracked in the first half of 2026, at least 16 have received investment from local state-owned funds. China's National Artificial Intelligence Industry Investment Fund (informally "Big Fund Phase III") made its first direct investment in the embodied intelligence sector by leading a RMB 2.5 billion (US$347.2 million) round into Galbot. Shenzhen Capital Group has backed more than 12 companies in the space. The Beijing Robot Fund holds its 3.83% Unitree stake as both a financial and strategic position.
The logic mirrors the electric vehicle buildout of the mid-2010s: a robot production line anchors a regional supply chain in motors, reducers, ball screws, sensors, and semiconductors, generating tax revenue and employment that justify the subsidy. Local governments competing for anchor tenants are offering not just capital but guaranteed deployment scenarios — a procurement-as-investment model that compresses the commercial validation timeline for early-stage companies.
IPO Window Narrows, Forcing a Triage Among Queued Candidates
The funding environment that preceded Unitree's listing was exceptional by any measure. According to IT Juzi data, total financing in China's domestic embodied intelligence sector reached RMB 93.5 billion (US$12.99 billion) in the first half of 2026, a fivefold increase versus the same period in 2025. Deal volume rose 137% year-on-year to 322 transactions. The number of companies carrying valuations above RMB 10 billion jumped from three at end-2025 to 22, with Galbot, X Square Robot, AI² Robotics, Galaxea AI each exceeding RMB 20 billion.
The public listing queue reflects this surge. On the A-share side, DEEP Robotics, Leju Robotics, and Dobot have each formally entered the IPO review process. Leju raised RMB 1.5 billion in a pre-IPO round at a post-money valuation of RMB 4.3 billion and is targeting ChiNext under the fourth listing standard, which prioritizes R&D intensity over near-term profitability. On the Hong Kong side, 10 companies with robot-related businesses completed listings in the first half of 2026, with 16 more in queue. AgiBot announced in July its intention to list in Hong Kong, with cornerstone investors targeting a valuation of HK$40 billion to HK$50 billion — a three-year journey from founding to IPO launch that has no precedent in China's hard-technology sector.
Companies that have completed share restructuring — including Galbot, Galaxea AI, LimX Dynamics, EngineAI, Noetix Robotics, ROBOTERA, Astribot, and Fourier Intelligence — are already queued. DexForce and AI² Robotics are weighing Hong Kong listings.
The window, however, is not permanent. Liu Yinghang, a partner at Scale Partners, warned that valuations at some companies have been driven to levels that embed significant bubble risk, with pricing more reflective of "dream multiples" than of demonstrated business progress. Once Unitree and its peers begin reporting quarterly results as public companies, secondary-market investors will price the sector on cash flows and order books. Lock-up expirations at multimodal AI companies that listed earlier in 2026 add a further overhang: any sustained sell-off in that cohort could transmit downward pressure to primary-market valuations. For companies that have not yet begun their restructuring, the effective window may close as early as end-2027.
Related Coverage:
Unitree Clears China's Fastest STAR Market Review, Eyes RMB 4.2 Billion War Chest